Product Information

ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1691 per EA under NDC 51672404501. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Sep 18, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB

Enalapril Maleate and Hydrochlorothiazide
$0.1691per EA

Strength

5; 12.5 mg/1; mg/1

NDC

51672404501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA075788

FDA Approved

9/18/2001

TE Code

AB

On Market Since

9/18/2001

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Decreased Blood Pressure
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 143.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1691 per EA
All-time high$0.2756 (Feb 12, 2020)
All-time low$0.0695 (Nov 28, 2013)
52-week high$0.1973
52-week low$0.1588
Median price$0.1559
Average price$0.1591
Largest weekly change+100.8% (Nov 19, 2014)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-10.0%

1M

-10.0%

3M

-9.3%

6M

-2.4%

1Y

+2.5%

3Y

-15.5%

5Y

+4.1%

All

+143.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Enalapril Maleate and Hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1691 per EA (NDC 51672404501), effective Aug 19, 2026.

How has the price of ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB has risen 143.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB?

Since Nov 28, 2013, the NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB has ranged from a low of $0.0695 (Nov 28, 2013) to a high of $0.2756 (Feb 12, 2020), with a median of $0.1559 per EA.

Are there cheaper alternatives to ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB?

ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB (NDC 51672404501) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.